{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T12:57:31Z","timestamp":1792760251732,"version":"4.5.0"},"reference-count":132,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jaci-inpractice.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Allergy and Clinical Immunology: In Practice"],"published-print":{"date-parts":[[2025,9]]},"DOI":"10.1016\/j.jaip.2025.07.025","type":"journal-article","created":{"date-parts":[[2025,7,26]],"date-time":"2025-07-26T15:04:12Z","timestamp":1753542252000},"page":"2221-2228","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":20,"title":["Pathogenesis of Chronic Spontaneous Urticaria With or Without Angioedema"],"prefix":"10.1016","volume":"13","author":[{"given":"Sarbjit S.","family":"Saini","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ricardo","family":"Asero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Massimo","family":"Cugno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hae-Sim","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric T.","family":"Oliver","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jaip.2025.07.025_bib1","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1038\/s41572-022-00389-z","article-title":"Urticaria","volume":"8","author":"Kolkhir","year":"2022","journal-title":"Nat Rev Dis Primers"},{"key":"10.1016\/j.jaip.2025.07.025_bib2","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1016\/j.iac.2024.03.002","article-title":"Chronic spontaneous urticaria: etiology and pathogenesis","volume":"44","author":"Oliver","year":"2024","journal-title":"Immunol Allergy Clin North Am"},{"key":"10.1016\/j.jaip.2025.07.025_bib3","doi-asserted-by":"crossref","first-page":"3515","DOI":"10.1016\/j.jaip.2023.08.020","article-title":"Patients with chronic spontaneous urticaria who have wheals, angioedema, or both, differ demographically, clinically, and in response to treatment-results from CURE","volume":"11","author":"Buttgereit","year":"2023","journal-title":"J Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jaip.2025.07.025_bib4","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1016\/j.iac.2024.03.003","article-title":"Chronic inducible urticaria","volume":"44","author":"Ritzel","year":"2024","journal-title":"Immunol Allergy Clin North Am"},{"key":"10.1016\/j.jaip.2025.07.025_bib5","doi-asserted-by":"crossref","first-page":"1715","DOI":"10.1111\/j.1398-9995.2009.02177.x","article-title":"The definition and diagnostic testing of physical and cholinergic urticarias\u2014EAACI\/GA2LEN\/EDF\/UNEV consensus panel recommendations","volume":"64","author":"Magerl","year":"2009","journal-title":"Allergy"},{"key":"10.1016\/j.jaip.2025.07.025_bib6","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1111\/all.12884","article-title":"The definition, diagnostic testing, and management of chronic inducible urticarias\u2014the EAACI\/GA(2) LEN\/EDF\/UNEV consensus recommendations 2016 update and revision","volume":"71","author":"Magerl","year":"2016","journal-title":"Allergy"},{"key":"10.1016\/j.jaip.2025.07.025_bib7","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1111\/j.1346-8138.2007.00276.x","article-title":"Chronic idiopathic urticaria: prevalence and clinical course","volume":"34","author":"Kulthanan","year":"2007","journal-title":"J Dermatol"},{"key":"10.1016\/j.jaip.2025.07.025_bib8","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1111\/all.15090","article-title":"The international EAACI\/GA(2)LEN\/EuroGuiDerm\/APAAACI guideline for the definition, classification, diagnosis, and management of urticaria","volume":"77","author":"Zuberbier","year":"2022","journal-title":"Allergy"},{"key":"10.1016\/j.jaip.2025.07.025_bib9","doi-asserted-by":"crossref","DOI":"10.1111\/pai.13925","article-title":"Differences between adult and pediatric chronic spontaneous urticaria from a cohort of 751 patients: clinical features, associated conditions and indicators of treatment response","volume":"34","author":"Ozceker","year":"2023","journal-title":"Pediatr Allergy Immunol"},{"key":"10.1016\/j.jaip.2025.07.025_bib10","doi-asserted-by":"crossref","first-page":"2284","DOI":"10.1016\/j.jaip.2021.03.038","article-title":"A comparative study of sex distribution, autoimmunity, blood, and inflammatory parameters in chronic spontaneous urticaria with angioedema and chronic histaminergic angioedema","volume":"9","author":"Sabate-Bresco","year":"2021","journal-title":"J Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jaip.2025.07.025_bib11","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1067\/mai.2002.123236","article-title":"TH1\/TH2 cytokines and inflammatory cells in skin biopsy specimens from patients with chronic idiopathic urticaria: comparison with the allergen-induced late-phase cutaneous reaction","volume":"109","author":"Ying","year":"2002","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2025.07.025_bib12","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/0091-6749(83)90096-9","article-title":"Histologic studies of chronic idiopathic urticaria","volume":"71","author":"Natbony","year":"1983","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2025.07.025_bib13","doi-asserted-by":"crossref","DOI":"10.1002\/clt2.12011","article-title":"Systemic and local evidence for complement involvement in chronic spontaneous urticaria","volume":"11","author":"Alizadeh Aghdam","year":"2021","journal-title":"Clin Transl Allergy"},{"issue":"Pt 1","key":"10.1016\/j.jaip.2025.07.025_bib14","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1016\/S0091-6749(99)70475-6","article-title":"Cutaneous inflammatory cell infiltrate in chronic idiopathic urticaria: comparison of patients with and without anti-FcepsilonRI or anti-IgE autoantibodies","volume":"103","author":"Sabroe","year":"1999","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2025.07.025_bib15","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1016\/j.coi.2008.09.005","article-title":"New concepts in chronic urticaria","volume":"20","author":"Vonakis","year":"2008","journal-title":"Curr Opin Immunol"},{"key":"10.1016\/j.jaip.2025.07.025_bib16","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/S1081-1206(10)60588-1","article-title":"Pathophysiology of chronic urticaria","volume":"100","author":"Brodell","year":"2008","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1016\/j.jaip.2025.07.025_bib17","doi-asserted-by":"crossref","first-page":"1819","DOI":"10.1016\/j.jaci.2022.04.010","article-title":"Autoimmune chronic spontaneous urticaria","volume":"149","author":"Kolkhir","year":"2022","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2025.07.025_bib18","doi-asserted-by":"crossref","first-page":"1269","DOI":"10.1111\/all.15585","article-title":"Anti-KIT antibody, barzolvolimab, reduces skin mast cells and disease activity in chronic inducible urticaria","volume":"78","author":"Terhorst-Molawi","year":"2023","journal-title":"Allergy"},{"key":"10.1016\/j.jaip.2025.07.025_bib19","doi-asserted-by":"crossref","DOI":"10.1111\/all.16598","article-title":"Anti-KIT barzolvolimab for chronic spontaneous urticaria","author":"Maurer","year":"2025","journal-title":"Allergy"},{"key":"10.1016\/j.jaip.2025.07.025_bib20","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1111\/j.1365-2222.1991.tb03198.x","article-title":"Detection of circulating histamine releasing autoantibodies with functional properties of anti-IgE in chronic urticaria","volume":"21","author":"Grattan","year":"1991","journal-title":"Clin Exp Allergy"},{"key":"10.1016\/j.jaip.2025.07.025_bib21","doi-asserted-by":"crossref","first-page":"1599","DOI":"10.1056\/NEJM199306033282204","article-title":"Autoantibodies against the high-affinity IgE receptor as a cause of histamine release in chronic urticaria","volume":"328","author":"Hide","year":"1993","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jaip.2025.07.025_bib22","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1016\/j.jaci.2017.10.035","article-title":"IL-24 is a common and specific autoantigen of IgE in chronic spontaneous urticaria","volume":"142","author":"Schmetzer","year":"2018","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2025.07.025_bib23","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/S0091-6749(99)70129-6","article-title":"Complement dependence of histamine release in chronic urticaria","volume":"104","author":"Ferrer","year":"1999","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2025.07.025_bib24","first-page":"43","article-title":"Activation of coagulation, anti-coagulation, fibrinolysis and the complement system in patients with urticaria","volume":"31","author":"Zhu","year":"2013","journal-title":"Asian Pac J Allergy Immunol"},{"key":"10.1016\/j.jaip.2025.07.025_bib25","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1111\/j.1600-0625.2009.00998.x","article-title":"Increased mast cell expression of PAR-2 in skin inflammatory diseases and release of IL-8 upon PAR-2 activation","volume":"19","author":"Carvalho","year":"2010","journal-title":"Exp Dermatol"},{"key":"10.1016\/j.jaip.2025.07.025_bib26","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1159\/000155748","article-title":"Expression of tissue factor by eosinophils in patients with chronic urticaria","volume":"148","author":"Cugno","year":"2009","journal-title":"Int Arch Allergy Immunol"},{"key":"10.1016\/j.jaip.2025.07.025_bib27","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1016\/j.jaci.2006.08.043","article-title":"Activation of the tissue factor pathway of blood coagulation in patients with chronic urticaria","volume":"119","author":"Asero","year":"2007","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2025.07.025_bib28","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.imlet.2023.11.008","article-title":"Mechanisms of histamine release from mast cells beyond the high affinity IgE receptor in severe chronic spontaneous urticaria","volume":"265","author":"Asero","year":"2024","journal-title":"Immunol Lett"},{"key":"10.1016\/j.jaip.2025.07.025_bib29","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1038\/nm1419","article-title":"Generation of C5a in the absence of C3: a new complement activation pathway","volume":"12","author":"Huber-Lang","year":"2006","journal-title":"Nat Med"},{"key":"10.1016\/j.jaip.2025.07.025_bib30","doi-asserted-by":"crossref","first-page":"1759","DOI":"10.3390\/cells10071759","article-title":"The role of coagulation and complement factors for mast cell activation in the pathogenesis of chronic spontaneous urticaria","volume":"10","author":"Yanase","year":"2021","journal-title":"Cells"},{"key":"10.1016\/j.jaip.2025.07.025_bib31","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1016\/j.jaci.2017.07.026","article-title":"Histamine and Toll-like receptor ligands synergistically induce endothelial cell gap formation by the extrinsic coagulating pathway","volume":"141","author":"Yanase","year":"2018","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2025.07.025_bib32","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1016\/j.jaci.2014.05.004","article-title":"Expression of Mas-related gene X2 on mast cells is upregulated in the skin of patients with severe chronic urticaria","volume":"134","author":"Fujisawa","year":"2014","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2025.07.025_bib33","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1016\/j.jaci.2020.08.027","article-title":"Mas-related G protein-coupled receptor X2 and its activators in dermatologic allergies","volume":"147","author":"Kuhn","year":"2021","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2025.07.025_bib34","doi-asserted-by":"crossref","first-page":"2833","DOI":"10.1038\/jid.2014.226","article-title":"Substance P is upregulated in serum of patients with chronic spontaneous urticaria","volume":"134","author":"Metz","year":"2014","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.jaip.2025.07.025_bib35","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1186\/s13601-019-0275-6","article-title":"Increased platelet activating factor levels in chronic spontaneous urticaria predicts refractoriness to antihistamine treatment: an observational study","volume":"9","author":"Ulambayar","year":"2019","journal-title":"Clin Transl Allergy"},{"key":"10.1016\/j.jaip.2025.07.025_bib36","doi-asserted-by":"crossref","first-page":"1066","DOI":"10.1159\/000516952","article-title":"Serum human \u03b2-defensin 2 is increased in angioedema accompanying chronic spontaneous urticaria","volume":"182","author":"Tra Cao","year":"2021","journal-title":"Int Arch Allergy Immunol"},{"key":"10.1016\/j.jaip.2025.07.025_bib37","doi-asserted-by":"crossref","first-page":"498","DOI":"10.4168\/aair.2021.13.3.498","article-title":"Elevated MRGPRX2 levels related to disease severity in patients with chronic spontaneous urticaria","volume":"13","author":"Cao","year":"2021","journal-title":"Allergy Asthma Immunol Res"},{"key":"10.1016\/j.jaip.2025.07.025_bib38","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1177\/10600280231168860","article-title":"Reply: drugs that interact with colchicine via inhibition of cytochrome P450 3A4 and P-glycoprotein: a signal detection analysis using a database of spontaneously reported adverse events (FAERS)","volume":"58","author":"Malone","year":"2024","journal-title":"Ann Pharmacother"},{"key":"10.1016\/j.jaip.2025.07.025_bib39","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1016\/j.jid.2020.06.030","article-title":"MRGPRX2 activation causes increased skin reactivity in patients with chronic spontaneous urticaria","volume":"141","author":"Shtessel","year":"2021","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.jaip.2025.07.025_bib40","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1016\/j.jaci.2024.07.002","article-title":"Inhibition of mast cell degranulation by novel small molecule MRGPRX2 antagonists","volume":"154","author":"Wollam","year":"2024","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2025.07.025_bib41","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1016\/j.alit.2023.05.001","article-title":"Urticaria and basophils","volume":"72","author":"Saini","year":"2023","journal-title":"Allergol Int"},{"key":"10.1016\/j.jaip.2025.07.025_bib42","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1111\/j.1365-2222.1974.tb01384.x","article-title":"Serum and cell bound IgE in chronic urticaria","volume":"4","author":"Greaves","year":"1974","journal-title":"Clin Allergy"},{"key":"10.1016\/j.jaip.2025.07.025_bib43","doi-asserted-by":"crossref","first-page":"1369","DOI":"10.1172\/JCI108405","article-title":"Defective histamine release in chronic urticaria","volume":"57","author":"Kern","year":"1976","journal-title":"J Clin Invest"},{"issue":"Pt 1","key":"10.1016\/j.jaip.2025.07.025_bib44","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1016\/S0091-6749(98)70283-0","article-title":"Anti-Fc(episilon)RI auto antibodies and basophil histamine releasability in chronic idiopathic urticaria","volume":"102","author":"Sabroe","year":"1998","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2025.07.025_bib45","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1111\/j.1365-2222.2005.02212.x","article-title":"Increased responsiveness of basophils of patients with chronic urticaria to sera but hypo-responsiveness to other stimuli","volume":"35","author":"Luquin","year":"2005","journal-title":"Clin Exp Allergy"},{"key":"10.1016\/j.jaip.2025.07.025_bib46","doi-asserted-by":"crossref","first-page":"1454","DOI":"10.1038\/jid.2015.13","article-title":"Suppression of basophil Fc\u03f5RI activation by serum from active chronic idiopathic\/spontaneous urticaria (CIU\/CSU) subjects","volume":"135","author":"Sterba","year":"2015","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.jaip.2025.07.025_bib47","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1016\/j.jaci.2006.09.035","article-title":"Basophil Fc\u03f5RI\u03b1 histamine release parallels expression of Src-homology 2-containing inositol phosphatases in chronic idiopathic urticaria","volume":"119","author":"Vonakis","year":"2007","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2025.07.025_bib48","doi-asserted-by":"crossref","first-page":"1956","DOI":"10.1038\/jid.2008.55","article-title":"Basophil phenotypes in chronic idiopathic urticaria in relation to disease activity and autoantibodies","volume":"128","author":"Eckman","year":"2008","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.jaip.2025.07.025_bib49","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1016\/S1081-1206(10)60449-8","article-title":"Basophil histamine release activity and disease severity in chronic idiopathic urticaria","volume":"100","author":"Baker","year":"2008","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1016\/j.jaip.2025.07.025_bib50","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1016\/j.jaip.2019.08.004","article-title":"Association of basophil parameters with disease severity and duration in chronic spontaneous urticaria (CSU)","volume":"8","author":"Huang","year":"2020","journal-title":"J Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jaip.2025.07.025_bib51","doi-asserted-by":"crossref","first-page":"1904","DOI":"10.1111\/all.13215","article-title":"Functional and phenotypic analysis of basophils allows determining distinct subtypes in patients with chronic urticaria","volume":"72","author":"Rauber","year":"2017","journal-title":"Allergy"},{"key":"10.1016\/j.jaip.2025.07.025_bib52","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.994823","article-title":"Basophils activation of patients with chronic spontaneous urticaria in response to C5a despite failure to respond to IgE-mediated stimuli","volume":"13","author":"Matsubara","year":"2022","journal-title":"Front Immunol"},{"key":"10.1016\/j.jaip.2025.07.025_bib53","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1111\/all.12578","article-title":"Interval shifts in basophil measures correlate with disease activity in chronic spontaneous urticaria","volume":"70","author":"Oliver","year":"2015","journal-title":"Allergy"},{"key":"10.1016\/j.jaip.2025.07.025_bib54","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1111\/j.1398-9995.1962.tb02937.x","article-title":"Basophilic leucopenia in different forms of urticaria","volume":"17","author":"Rorsman","year":"1962","journal-title":"Acta Allergol"},{"key":"10.1016\/j.jaip.2025.07.025_bib55","doi-asserted-by":"crossref","first-page":"1417","DOI":"10.1111\/j.1365-2222.1997.tb02986.x","article-title":"Flow cytometric analysis of basophil numbers in chronic urticaria: basopenia is related to serum histamine releasing activity","volume":"27","author":"Grattan","year":"1997","journal-title":"Clin Exp Allergy"},{"key":"10.1016\/j.jaip.2025.07.025_bib56","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1111\/bjd.12991","article-title":"Elevations in vascular markers and eosinophils in chronic spontaneous urticarial weals with low-level persistence in uninvolved skin","volume":"171","author":"Kay","year":"2014","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jaip.2025.07.025_bib57","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1111\/j.1398-9995.2011.02570.x","article-title":"Basophil recruitment and activation in inflammatory skin diseases","volume":"66","author":"Ito","year":"2011","journal-title":"Allergy"},{"key":"10.1016\/j.jaip.2025.07.025_bib58","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1034\/j.1600-0625.2003.00010.x","article-title":"Infiltrating cells and related cytokines in lesional skin of patients with chronic idiopathic urticaria and positive autologous serum skin test","volume":"12","author":"Caproni","year":"2003","journal-title":"Exp Dermatol"},{"key":"10.1016\/j.jaip.2025.07.025_bib59","doi-asserted-by":"crossref","first-page":"e155","DOI":"10.1111\/jdv.20204","article-title":"Basophil and eosinophil recruitment to skin lesions is linked to features of autoimmune chronic spontaneous urticaria including basopenia","volume":"39","author":"Jiao","year":"2025","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.jaip.2025.07.025_bib60","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1016\/j.jaci.2015.06.004","article-title":"Altered expression of chemoattractant receptor-homologous molecule expressed on T(H)2 cells on blood basophils and eosinophils in patients with chronic spontaneous urticaria","volume":"137","author":"Oliver","year":"2016","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2025.07.025_bib61","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1111\/cea.14523","article-title":"Low CCR3 expression is a marker of active disease in chronic spontaneous urticaria","volume":"54","author":"Bellamy","year":"2024","journal-title":"Clin Exp Allergy"},{"key":"10.1016\/j.jaip.2025.07.025_bib62","doi-asserted-by":"crossref","first-page":"460","DOI":"10.2500\/aap.2011.32.3483","article-title":"Clinical and laboratory features of antihistamine-resistant chronic idiopathic urticaria","volume":"32","author":"Magen","year":"2011","journal-title":"Allergy Asthma Proc"},{"key":"10.1016\/j.jaip.2025.07.025_bib63","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1046\/j.1365-2222.2003.01589.x","article-title":"Blood basophil numbers in chronic ordinary urticaria and healthy controls: diurnal variation, influence of loratadine and prednisolone and relationship to disease activity","volume":"33","author":"Grattan","year":"2003","journal-title":"Clin Exp Allergy"},{"key":"10.1016\/j.jaip.2025.07.025_bib64","doi-asserted-by":"crossref","first-page":"958","DOI":"10.1016\/j.jid.2016.11.025","article-title":"Effect of omalizumab on blood basophil counts in patients with chronic idiopathic\/spontaneous urticaria","volume":"137","author":"Saini","year":"2017","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.jaip.2025.07.025_bib65","doi-asserted-by":"crossref","first-page":"2271","DOI":"10.1016\/j.jaci.2021.02.038","article-title":"The efficacy of omalizumab treatment in chronic spontaneous urticaria is associated with basophil phenotypes","volume":"147","author":"Johal","year":"2021","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2025.07.025_bib66","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1111\/cea.12875","article-title":"Human basophils are a source of\u2014and are differentially activated by\u2014IL-31","volume":"47","author":"Raap","year":"2017","journal-title":"Clin Exp Allergy"},{"key":"10.1016\/j.jaip.2025.07.025_bib67","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1111\/j.1600-0625.2010.01067.x","article-title":"Increased levels of serum IL-31 in chronic spontaneous urticaria","volume":"19","author":"Raap","year":"2010","journal-title":"Exp Dermatol"},{"key":"10.1016\/j.jaip.2025.07.025_bib68","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1016\/j.jaci.2024.01.028","article-title":"Dupilumab in patients with chronic spontaneous urticaria (LIBERTY-CSU CUPID): two randomized, double-blind, placebo-controlled, phase 3 trials","volume":"154","author":"Maurer","year":"2024","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2025.07.025_bib69","doi-asserted-by":"crossref","first-page":"1510","DOI":"10.1016\/j.jaci.2020.03.005","article-title":"The role of eosinophils in chronic spontaneous urticaria","volume":"145","author":"Altrichter","year":"2020","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2025.07.025_bib70","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1016\/j.jaip.2019.08.025","article-title":"Eosinopenia, in chronic spontaneous urticaria, is associated with high disease activity, autoimmunity, and poor response to treatment","volume":"8","author":"Kolkhir","year":"2020","journal-title":"J Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jaip.2025.07.025_bib71","first-page":"21","article-title":"Serum levels of eosinophil-derived neurotoxin in patients with chronic urticaria","volume":"13","author":"Saleh","year":"2020","journal-title":"J Clin Aesthet Dermatol"},{"key":"10.1016\/j.jaip.2025.07.025_bib72","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1111\/1523-1747.ep12538380","article-title":"Localization of eosinophil granule major basic protein in chronic urticaria","volume":"81","author":"Peters","year":"1983","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.jaip.2025.07.025_bib73","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1155\/S0962935196000191","article-title":"Blood eosinophils and serum eosinophil cationic protein in patients with acute and chronic urticaria","volume":"5","author":"Lorenzo","year":"1996","journal-title":"Mediators Inflamm"},{"key":"10.1016\/j.jaip.2025.07.025_bib74","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1093\/bjd\/ljae067","article-title":"Benralizumab does not elicit therapeutic effect in patients with chronic spontaneous urticaria: results from the phase IIb multinational randomized double-blind placebo-controlled ARROYO trial","volume":"191","author":"Altrichter","year":"2024","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jaip.2025.07.025_bib75","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1016\/j.anai.2024.05.020","article-title":"The future of targeted therapy in chronic spontaneous urticaria","volume":"133","author":"Min","year":"2024","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1016\/j.jaip.2025.07.025_bib76","first-page":"179","article-title":"Unveiling the role of neutrophils in chronic spontaneous urticaria: beyond mast cells","volume":"41","author":"Kulthanan","year":"2023","journal-title":"Asian Pac J Allergy Immunol"},{"key":"10.1016\/j.jaip.2025.07.025_bib77","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1067\/mai.2002.121314","article-title":"Evidence for aberrant regulation of the p21Ras pathway in PBMCs of patients with chronic idiopathic urticaria","volume":"109","author":"Confino-Cohen","year":"2002","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2025.07.025_bib78","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1080\/000155502320323199","article-title":"Cytokine production of CD4+ and CD8+ peripheral T lymphocytes in patients with chronic idiopathic urticaria","volume":"82","author":"Irinyi","year":"2002","journal-title":"Acta Derm Venereol"},{"key":"10.1016\/j.jaip.2025.07.025_bib79","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1159\/000058004","article-title":"Immune profiles of patients with chronic idiopathic urticaria","volume":"128","author":"Piconi","year":"2002","journal-title":"Int Arch Allergy Immunol"},{"key":"10.1016\/j.jaip.2025.07.025_bib80","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.cyto.2004.03.016","article-title":"Low stimulated IL-4 secretion in PBMC from patients with chronic idiopathic urticaria","volume":"27","author":"Confino-Cohen","year":"2004","journal-title":"Cytokine"},{"key":"10.1016\/j.jaip.2025.07.025_bib81","doi-asserted-by":"crossref","first-page":"1433","DOI":"10.1016\/j.intimp.2008.05.016","article-title":"Increased circulating pro-inflammatory cytokines and imbalanced regulatory T-cell cytokines production in chronic idiopathic urticaria","volume":"8","author":"Dos Santos","year":"2008","journal-title":"Int Immunopharmacol"},{"key":"10.1016\/j.jaip.2025.07.025_bib82","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1080\/00015550410026939","article-title":"Chronic idiopathic and chronic autoimmune urticaria: clinical and immunopathological features of 68 subjects","volume":"84","author":"Caproni","year":"2004","journal-title":"Acta Derm Venereol"},{"key":"10.1016\/j.jaip.2025.07.025_bib83","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1016\/j.humimm.2012.03.016","article-title":"Elevated serum B-cell activating factor in patients with chronic urticaria","volume":"73","author":"Kessel","year":"2012","journal-title":"Hum Immunol"},{"key":"10.1016\/j.jaip.2025.07.025_bib84","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1016\/j.jdermsci.2013.03.003","article-title":"Histamine, TNF, C5a, IL-6, -9, -18, -31, -33, TSLP, neopterin, and VEGF are not elevated in chronic spontaneous urticaria","volume":"70","author":"Metz","year":"2013","journal-title":"J Dermatol Sci"},{"key":"10.1016\/j.jaip.2025.07.025_bib85","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-017-18187-z","article-title":"Increased plasma IL-17, IL-31, and IL-33 levels in chronic spontaneous urticaria","volume":"7","author":"Lin","year":"2017","journal-title":"Sci Rep"},{"key":"10.1016\/j.jaip.2025.07.025_bib86","doi-asserted-by":"crossref","first-page":"2765","DOI":"10.3390\/biomedicines12122765","article-title":"Alarmins in chronic spontaneous urticaria: immunological insights and therapeutic perspectives","volume":"12","author":"Rizzi","year":"2024","journal-title":"Biomedicines"},{"key":"10.1016\/j.jaip.2025.07.025_bib87","doi-asserted-by":"crossref","first-page":"1945","DOI":"10.1016\/j.jaci.2025.01.045","article-title":"Tezepelumab for the treatment of chronic spontaneous urticaria: results of the phase 2b INCEPTION study","volume":"155","author":"McLaren","year":"2025","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2025.07.025_bib88","doi-asserted-by":"crossref","first-page":"1108","DOI":"10.1016\/j.jaip.2018.02.024","article-title":"Emerging biomarkers and therapeutic pipelines for chronic spontaneous urticaria","volume":"6","author":"Deza","year":"2018","journal-title":"J Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jaip.2025.07.025_bib89","doi-asserted-by":"crossref","first-page":"1271","DOI":"10.1111\/j.1365-2133.2010.10198.x","article-title":"Impaired IFN-\u03b1 secretion by plasmacytoid dendritic cells induced by TLR9 activation in chronic idiopathic urticaria","volume":"164","author":"Futata","year":"2011","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jaip.2025.07.025_bib90","doi-asserted-by":"crossref","first-page":"2195","DOI":"10.1016\/j.jaip.2021.03.033","article-title":"The pathogenesis of chronic spontaneous urticaria: the role of infiltrating cells","volume":"9","author":"Gimenez-Arnau","year":"2021","journal-title":"J Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jaip.2025.07.025_bib91","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1111\/j.1365-2133.1986.tb04065.x","article-title":"A serological mediator in chronic idiopathic urticaria\u2014a clinical, immunological and histological evaluation","volume":"114","author":"Grattan","year":"1986","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jaip.2025.07.025_bib92","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1111\/1523-1747.ep12462239","article-title":"Prevalence and functional role of anti-IgE autoantibodies in urticarial syndromes","volume":"90","author":"Gruber","year":"1988","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.jaip.2025.07.025_bib93","doi-asserted-by":"crossref","first-page":"3208","DOI":"10.1111\/all.14412","article-title":"IgM and IgA in addition to IgG autoantibodies against Fc\u03f5RI\u03b1 are frequent and associated with disease markers of chronic spontaneous urticaria","volume":"75","author":"Altrichter","year":"2020","journal-title":"Allergy"},{"key":"10.1016\/j.jaip.2025.07.025_bib94","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0014794","article-title":"IgE mediated autoallergy against thyroid peroxidase\u2014a novel pathomechanism of chronic spontaneous urticaria?","volume":"6","author":"Altrichter","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.jaip.2025.07.025_bib95","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1111\/cei.13428","article-title":"Co-occurrence of IgE and IgG autoantibodies in patients with chronic spontaneous urticaria","volume":"200","author":"Asero","year":"2020","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.jaip.2025.07.025_bib96","doi-asserted-by":"crossref","first-page":"746","DOI":"10.4168\/aair.2021.13.5.746","article-title":"Presence of IgE autoantibodies against eosinophil peroxidase and eosinophil cationic protein in severe chronic spontaneous urticaria and atopic dermatitis","volume":"13","author":"Sanchez","year":"2021","journal-title":"Allergy Asthma Immunol Res"},{"key":"10.1016\/j.jaip.2025.07.025_bib97","doi-asserted-by":"crossref","first-page":"2417","DOI":"10.1016\/j.jaip.2023.02.006","article-title":"Most patients with autoimmune chronic spontaneous urticaria also have autoallergic urticaria, but not vice versa","volume":"11","author":"Xiang","year":"2023","journal-title":"J Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jaip.2025.07.025_bib98","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1016\/j.iac.2024.07.001","article-title":"Chronic spontaneous urticaria: current and emerging biologic agents","volume":"44","author":"Bernstein","year":"2024","journal-title":"Immunol Allergy Clin North Am"},{"key":"10.1016\/j.jaip.2025.07.025_bib99","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1016\/j.anai.2024.10.026","article-title":"Endotypes, phenotypes, and biomarkers in chronic spontaneous urticaria: evolving toward personalized medicine","volume":"134","author":"Lang","year":"2025","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1016\/j.jaip.2025.07.025_bib100","doi-asserted-by":"crossref","first-page":"2411","DOI":"10.1016\/j.jaip.2023.05.039","article-title":"Positive basophil tests are linked to high disease activity and other features of autoimmune chronic spontaneous urticaria: a systematic review","volume":"11","author":"Monino-Romero","year":"2023","journal-title":"J Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jaip.2025.07.025_bib101","doi-asserted-by":"crossref","first-page":"545","DOI":"10.4168\/aair.2021.13.4.545","article-title":"Autoimmune diseases are linked to type IIb autoimmune chronic spontaneous urticaria","volume":"13","author":"Kolkhir","year":"2021","journal-title":"Allergy Asthma immunol Res"},{"key":"10.1016\/j.jaip.2025.07.025_bib102","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1093\/ced\/llae441","article-title":"Relevance of the basophil activation test in a cohort of 240 patients with chronic spontaneous urticaria","volume":"50","author":"Pesque","year":"2025","journal-title":"Clin Exp Dermatol"},{"key":"10.1016\/j.jaip.2025.07.025_bib103","doi-asserted-by":"crossref","first-page":"1256","DOI":"10.1111\/j.1398-9995.2009.02132.x","article-title":"EAACI\/GA(2)LEN task force consensus report: the autologous serum skin test in urticaria","volume":"64","author":"Konstantinou","year":"2009","journal-title":"Allergy"},{"key":"10.1016\/j.jaip.2025.07.025_bib104","doi-asserted-by":"crossref","first-page":"2302","DOI":"10.1016\/j.jaip.2023.02.022","article-title":"Chronic spontaneous urticaria: the role and relevance of autoreactivity, autoimmunity and autoallergy","volume":"11","author":"Asero","year":"2023","journal-title":"J Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jaip.2025.07.025_bib105","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1111\/j.1365-2222.2006.02494.x","article-title":"Evidence of in vivo basophil activation in chronic idiopathic urticaria","volume":"36","author":"Vasagar","year":"2006","journal-title":"Clin Exp Allergy"},{"key":"10.1016\/j.jaip.2025.07.025_bib106","doi-asserted-by":"crossref","first-page":"1584","DOI":"10.1038\/jid.2008.416","article-title":"Independent evaluation of a commercial test for \"autoimmune\" urticaria in normal and chronic urticaria subjects","volume":"129","author":"Eckman","year":"2009","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.jaip.2025.07.025_bib107","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.anai.2012.10.020","article-title":"Autoantibodies in chronic idiopathic urticaria and nonurticarial systemic autoimmune disorders","volume":"110","author":"Cho","year":"2013","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1016\/j.jaip.2025.07.025_bib108","doi-asserted-by":"crossref","first-page":"1100","DOI":"10.1016\/j.jaci.2018.05.019","article-title":"Autoantibodies to IgE and Fc\u03b5RI and the natural variability of spleen tyrosine kinase expression in basophils","volume":"143","author":"MacGlashan","year":"2019","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2025.07.025_bib109","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1111\/j.1468-3083.2006.01852.x","article-title":"The autologous serum skin test in a cohort of chronic idiopathic urticaria patients compared to respiratory allergy patients and healthy individuals","volume":"21","author":"Guttman-Yassky","year":"2007","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.jaip.2025.07.025_bib110","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1111\/j.1398-9995.2005.00673.x","article-title":"The autologous serum skin test in the follow-up of patients with chronic urticaria","volume":"60","author":"Fusari","year":"2005","journal-title":"Allergy"},{"key":"10.1016\/j.jaip.2025.07.025_bib111","doi-asserted-by":"crossref","first-page":"2427","DOI":"10.1111\/all.13949","article-title":"Biomarkers and clinical characteristics of autoimmune chronic spontaneous urticaria: results of the PURIST Study","volume":"74","author":"Schoepke","year":"2019","journal-title":"Allergy"},{"key":"10.1016\/j.jaip.2025.07.025_bib112","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1016\/j.jaci.2008.07.006","article-title":"Treatment of chronic autoimmune urticaria with omalizumab","volume":"122","author":"Kaplan","year":"2008","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2025.07.025_bib113","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1111\/cea.12870","article-title":"Potential blood biomarkers in chronic spontaneous urticaria","volume":"47","author":"Kolkhir","year":"2017","journal-title":"Clin Exp Allergy"},{"key":"10.1016\/j.jaip.2025.07.025_bib114","doi-asserted-by":"crossref","first-page":"55","DOI":"10.23822\/EurAnnACI.1764-1489.132","article-title":"Correlations between disease activity, autoimmunity and biological parameters in patients with chronic spontaneous urticaria","volume":"53","author":"de Montjoye","year":"2021","journal-title":"Eur Ann Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2025.07.025_bib115","doi-asserted-by":"crossref","first-page":"940","DOI":"10.1111\/all.13352","article-title":"C-reactive protein is linked to disease activity, impact, and response to treatment in patients with chronic spontaneous urticaria","volume":"73","author":"Kolkhir","year":"2018","journal-title":"Allergy"},{"key":"10.1016\/j.jaip.2025.07.025_bib116","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1016\/j.jaci.2016.07.047","article-title":"Serum autoreactivity predicts time to response to omalizumab therapy in chronic spontaneous urticaria","volume":"139","author":"Gericke","year":"2017","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2025.07.025_bib117","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1016\/j.jaip.2015.11.025","article-title":"Lack of basophil CD203c-upregulating activity as an immunological marker to predict response to treatment with omalizumab in patients with symptomatic chronic urticaria","volume":"4","author":"Palacios","year":"2016","journal-title":"J Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jaip.2025.07.025_bib118","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1111\/bjd.14540","article-title":"Effectiveness and safety of omalizumab in chronic spontaneous or inducible urticaria: evaluation of 154 patients","volume":"175","author":"Ghazanfar","year":"2016","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jaip.2025.07.025_bib119","doi-asserted-by":"crossref","first-page":"2295","DOI":"10.1016\/j.jaci.2021.02.039","article-title":"Response of peripheral blood basophils in subjects with chronic spontaneous urticaria during treatment with omalizumab","volume":"147","author":"MacGlashan","year":"2021","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2025.07.025_bib120","article-title":"Utility of serum biomarkers in real-world practice for predicting response to omalizumab therapy in patients with chronic spontaneous urticaria","volume":"4","author":"Cain","year":"2025","journal-title":"J Allergy Clin Immunol Glob"},{"key":"10.1016\/j.jaip.2025.07.025_bib121","doi-asserted-by":"crossref","first-page":"866","DOI":"10.1159\/000532021","article-title":"Anti-TPO IgG\/total IgE ratio: biomarker for omalizumab response prediction in chronic spontaneous urticaria","volume":"184","author":"Bras","year":"2023","journal-title":"Int Arch Allergy Immunol"},{"key":"10.1016\/j.jaip.2025.07.025_bib122","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1111\/cea.13066","article-title":"Double-blind placebo-controlled trial of the effect of omalizumab on basophils in chronic urticaria patients","volume":"48","author":"Jorg","year":"2018","journal-title":"Clin Exp Allergy"},{"key":"10.1016\/j.jaip.2025.07.025_bib123","doi-asserted-by":"crossref","first-page":"1386","DOI":"10.1016\/j.jaip.2017.10.030","article-title":"Serum IgE as an immunological marker to predict response to omalizumab treatment in symptomatic chronic urticaria","volume":"6","author":"Straesser","year":"2018","journal-title":"J Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jaip.2025.07.025_bib124","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1111\/all.13345","article-title":"The clinical response to omalizumab in chronic spontaneous urticaria patients is linked to and predicted by IgE levels and their change","volume":"73","author":"Ertas","year":"2018","journal-title":"Allergy"},{"key":"10.1016\/j.jaip.2025.07.025_bib125","doi-asserted-by":"crossref","first-page":"2406","DOI":"10.1111\/all.13586","article-title":"Total IgE levels are linked to the response of chronic spontaneous urticaria patients to omalizumab","volume":"73","author":"Weller","year":"2018","journal-title":"Allergy"},{"key":"10.1016\/j.jaip.2025.07.025_bib126","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1111\/jdv.15350","article-title":"Predictors of response to omalizumab and relapse in chronic spontaneous urticaria: a study of 470 patients","volume":"33","author":"Marzano","year":"2019","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.jaip.2025.07.025_bib127","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1016\/S0140-6736(24)00852-3","article-title":"Chronic urticaria: unmet needs, emerging drugs, and new perspectives on personalised treatment","volume":"404","author":"Zuberbier","year":"2024","journal-title":"Lancet"},{"key":"10.1016\/j.jaip.2025.07.025_bib128","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1016\/j.alit.2018.09.006","article-title":"Identification of biomarkers for predicting the response to cyclosporine A therapy in patients with chronic spontaneous urticaria","volume":"68","author":"Endo","year":"2019","journal-title":"Allergol Int"},{"key":"10.1016\/j.jaip.2025.07.025_bib129","doi-asserted-by":"crossref","DOI":"10.1016\/j.jaci.2025.05.030","article-title":"Current and future landscape of Bruton tyrosine kinase inhibitors in allergy","author":"Lin","year":"2025","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2025.07.025_bib130","doi-asserted-by":"crossref","first-page":"1961","DOI":"10.1038\/s41591-021-01537-w","article-title":"Fenebrutinib in H1 antihistamine-refractory chronic spontaneous urticaria: a randomized phase 2 trial","volume":"27","author":"Metz","year":"2021","journal-title":"Nat Med"},{"key":"10.1016\/j.jaip.2025.07.025_bib131","doi-asserted-by":"crossref","first-page":"1498","DOI":"10.1016\/j.jaci.2022.08.027","article-title":"Remibrutinib, a novel BTK inhibitor, demonstrates promising efficacy and safety in chronic spontaneous urticaria","volume":"150","author":"Maurer","year":"2022","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2025.07.025_bib132","doi-asserted-by":"crossref","first-page":"984","DOI":"10.1056\/NEJMoa2408792","article-title":"Remibrutinib in chronic spontaneous urticaria","volume":"392","author":"Metz","year":"2025","journal-title":"N Engl J Med"}],"container-title":["The Journal of Allergy and Clinical Immunology: In Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213219825007159?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213219825007159?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,13]],"date-time":"2025-09-13T15:01:07Z","timestamp":1757775667000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213219825007159"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9]]},"references-count":132,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2025,9]]}},"alternative-id":["S2213219825007159"],"URL":"https:\/\/doi.org\/10.1016\/j.jaip.2025.07.025","relation":{},"ISSN":["2213-2198"],"issn-type":[{"value":"2213-2198","type":"print"}],"subject":[],"published":{"date-parts":[[2025,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Pathogenesis of Chronic Spontaneous Urticaria With or Without Angioedema","name":"articletitle","label":"Article Title"},{"value":"The Journal of Allergy and Clinical Immunology: In Practice","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jaip.2025.07.025","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 American Academy of Allergy, Asthma & Immunology","name":"copyright","label":"Copyright"}]}}